n-Boc-4-(2-cyclopropyl-4-hydroxymethyl-2h-pyrazol-3-yl)-piperidine → N-Boc-4-(2-cyclopropyl-4-formyl-2H-pyrazol-3-yl)-piperidine

HRID 2109283Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2109283
[C:1]([N:8]1[CH2:13][CH2:12][CH:11]([C:14]2[N:15]([CH:21]3[CH2:23][CH2:22]3)[N:16]=[CH:17][C:18]=2[CH2:19][OH:20])[CH2:10][CH2:9]1)([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2]>C1COCC1.O=[Mn]=O>[C:1]([N:8]1[CH2:9][CH2:10][CH:11]([C:14]2[N:15]([CH:21]3[CH2:23][CH2:22]3)[N:16]=[CH:17][C:18]=2[CH:19]=[O:20])[CH2:12][CH2:13]1)([O:3][C:4]([CH3:7])([CH3:6])[CH3:5])=[O:2]

Komponenten

4

Edukt 1

HCID 21097374n-Boc-4-(2-cyclopropyl-4-hydroxymethyl-2h-pyrazol-3-yl)-piperidine

Produkt 1

HCID 21097373N-Boc-4-(2-cyclopropyl-4-formyl-2H-pyrazol-3-yl)-piperidineAusbeute 70,7 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 14801Manganese dioxideKatalysatorHCID 8028TetrahydrofuranLösungsmittel

Versuchsvorschrift

The above acid (300 mg, 0.894 mmol) was dissolved in 5 mL of THF. To this solution was added 3.58 mL (3.58 mmol) of 1M borane in THF. After stirring for 5 h, the mixture was poured into 15 mL of 5% HCl. The solution was extracted with 200 mL of EtOAc, and the extract was washed with saturated NaHCO3 and brine, dried over MgSO4, filtered, concentrated, and chromatographed (10-100 EtOAc in hexanes) to give 120 mg of N-Boc-4-(2-cyclopropyl-4-hydroxymethyl-2H-pyrazol-3-yl)-piperidine. This alcohol (100 mg, 0.31 mmol) was stirred overnight in 10 mL of THF with 270 mg (3.1 mmol) of activated MnO2. The mixture was filtered and concentrated to provide 70 mg of N-Boc-4-(2-cyclopropyl-4-formyl-2H-pyrazol-3-yl)-piperidine.

Aufarbeitung

  1. filtrationThe mixture was filtered
  2. concentrationconcentrated

Quellen und Nachweise

ORD-Eintrag
ord-e31c00b9e0304a79b001f5baf7be8f35
Quelldatensatz
uspto-grants-2009_04
Patentnummer
US07514458B2

Notizen zur Reaktion

Wird geladen…